Monthly injections of fitusiran found to reduce bleeds in patients with hemophilia A and B

by

Monthly prophylactic injections of fitusiran are effective in reducing bleeds in patients with hemophilia A or B, according to randomized controlled trials publishing simultaneously in The Lancet and The Lancet Haematology journals.

Leave A Comment

Your email address will not be published. Required fields are marked *